 |
PDBsum entry 1kjs
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Cell adhesion
|
PDB id
|
|
|
|
1kjs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Proteins
28:261-267
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural definition of the C5a C terminus by two-dimensional nuclear magnetic resonance spectroscopy.
|
|
X.Zhang,
W.Boyar,
M.J.Toth,
L.Wennogle,
N.C.Gonnella.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The serum glycoprotein C5a, which is derived from the proteolytic cleavage of
complement protein C5, has been implicated in the pathogenesis of a number of
inflammatory and allergic conditions. Because C5a induces an inflammatory
response upon binding to a specific receptor, structural and mutagenesis studies
were carried out to gain a better understanding of this binding interaction.
These studies led to the first structural definition of the C terminus of
recombinant human (rh)-C5a, determined by two-dimensional nuclear magnetic
resonance (NMR) spectroscopy. Our results show that the C terminus adopts an
alpha-helical conformation spanning residues 69 to 74, while the core domain
exists as an antiparallel alpha-helical bundle. This C-terminal helix is
connected to the core by a short loop that orients Arg 74 adjacent to Arg 62.
Point mutation analysis had already revealed that residues 62 and 74
significantly contribute to agonist activity and receptor binding. Correlation
of the C5a tertiary structure with mutational analyses clarifies the
significance of the functional and binding properties of Arg 62 and suggests
that both Arg 62 and Arg 74 interact at the same binding site on the receptor.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
W.J.Cook,
N.Galakatos,
W.C.Boyar,
R.L.Walter,
and
S.E.Ealick
(2010).
Structure of human desArg-C5a.
|
| |
Acta Crystallogr D Biol Crystallogr,
66,
190-197.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.H.Ippel,
C.J.de Haas,
A.Bunschoten,
J.A.van Strijp,
J.A.Kruijtzer,
R.M.Liskamp,
and
J.Kemmink
(2009).
Structure of the Tyrosine-sulfated C5a Receptor N Terminus in Complex with Chemotaxis Inhibitory Protein of Staphylococcus aureus.
|
| |
J Biol Chem,
284,
12363-12372.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Lee,
P.L.Whitfeld,
and
C.R.Mackay
(2008).
Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2.
|
| |
Immunol Cell Biol,
86,
153-160.
|
 |
|
|
|
|
 |
J.D.Lambris,
D.Ricklin,
and
B.V.Geisbrecht
(2008).
Complement evasion by human pathogens.
|
| |
Nat Rev Microbiol,
6,
132-142.
|
 |
|
|
|
|
 |
M.Pasupuleti,
B.Walse,
E.A.Nordahl,
M.Mörgelin,
M.Malmsten,
and
A.Schmidtchen
(2007).
Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans.
|
| |
J Biol Chem,
282,
2520-2528.
|
 |
|
|
|
|
 |
P.N.Monk,
A.M.Scola,
P.Madala,
and
D.P.Fairlie
(2007).
Function, structure and therapeutic potential of complement C5a receptors.
|
| |
Br J Pharmacol,
152,
429-448.
|
 |
|
|
|
|
 |
P.Roversi,
O.Lissina,
S.Johnson,
N.Ahmat,
G.C.Paesen,
K.Ploss,
W.Boland,
M.A.Nunn,
and
S.M.Lea
(2007).
The structure of OMCI, a novel lipocalin inhibitor of the complement system.
|
| |
J Mol Biol,
369,
784-793.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
I.S.Hagemann,
K.D.Narzinski,
D.H.Floyd,
and
T.J.Baranski
(2006).
Random mutagenesis of the complement factor 5a (C5a) receptor N terminus provides a structural constraint for C5a docking.
|
| |
J Biol Chem,
281,
36783-36792.
|
 |
|
|
|
|
 |
C.K.Brown,
Z.Y.Gu,
Y.V.Matsuka,
S.S.Purushothaman,
L.A.Winter,
P.P.Cleary,
S.B.Olmsted,
D.H.Ohlendorf,
and
C.A.Earhart
(2005).
Structure of the streptococcal cell wall C5a peptidase.
|
| |
Proc Natl Acad Sci U S A,
102,
18391-18396.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Shrestha,
M.Shiokawa,
T.Nishimura,
H.Nishiura,
Y.Tanaka,
N.Nishino,
Y.Shibuya,
and
T.Yamamoto
(2003).
Switch moiety in agonist/antagonist dual effect of S19 ribosomal protein dimer on leukocyte chemotactic C5a receptor.
|
| |
Am J Pathol,
162,
1381-1388.
|
 |
|
|
|
|
 |
Y.Shibuya,
M.Shiokawa,
H.Nishiura,
T.Nishimura,
N.Nishino,
H.Okabe,
K.Takagi,
and
T.Yamamoto
(2001).
Identification of receptor-binding sites of monocyte chemotactic S19 ribosomal protein dimer.
|
| |
Am J Pathol,
159,
2293-2301.
|
 |
|
|
|
|
 |
T.J.Baranski,
P.Herzmark,
O.Lichtarge,
B.O.Gerber,
J.Trueheart,
E.C.Meng,
T.Iiri,
S.P.Sheikh,
and
H.R.Bourne
(1999).
C5a receptor activation. Genetic identification of critical residues in four transmembrane helices.
|
| |
J Biol Chem,
274,
15757-15765.
|
 |
|
|
|
|
 |
Z.Chen,
X.Zhang,
N.C.Gonnella,
T.C.Pellas,
W.C.Boyar,
and
F.Ni
(1998).
Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin.
|
| |
J Biol Chem,
273,
10411-10419.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |